Heilmann Volker, Kreienberg Rolf
Department of Obstetrics and Gynecology, University of Ulm, Prittwitzstr. 43, 89075 Ulm, Germany.
Curr Womens Health Rep. 2002 Feb;2(1):27-33.
There is strong clinical and experimental evidence that the human papilloma virus (HPV) plays a central role in the development and growth of cervical cancer. However, it is known that the carcinogenesis is a multistep process. Changes in the cytogenetic equilibrium, such as chromosomal imbalances, allelic loss, and structural aberrations, happen during the transformation from normal epithelium to cervical cancer. Numerous studies support the hypothesis that HPV infection is associated with development of malignant or pre-malignant changes of the lower genital tract. However, there is little clinical evidence that HPV detection would allow prediction of development of cervical cancer. Regarding the "human aspect" of carcinogenesis, there are efforts to detect markers that predict the risk of progression.
有强有力的临床和实验证据表明,人乳头瘤病毒(HPV)在宫颈癌的发生和发展中起核心作用。然而,众所周知,致癌作用是一个多步骤过程。在从正常上皮组织向宫颈癌转变的过程中,会发生细胞遗传平衡的改变,如染色体失衡、等位基因缺失和结构畸变。众多研究支持这样的假说,即HPV感染与下生殖道恶性或癌前病变的发生有关。然而,几乎没有临床证据表明检测HPV能预测宫颈癌的发展。关于致癌作用的“人为因素”,人们正在努力寻找能够预测病情进展风险的标志物。